Calicheamicin
Safety Information
Hazard Statements
Precautionary Statements
Pictograms
Product Description
Calicheamicin is a highly potent natural product antibiotic isolated from the bacterium Micromonospora echinospora var. calichensis. It exhibits exceptional cytotoxicity against a wide range of human cancer cell lines, making it a subject of interest for cancer research and potential therapeutic development. Despite its promising activity, the use of calicheamicin in medicine is limited by its extreme potency and potential for causing severe toxic effects. Research focuses on developing less toxic analogs or delivery systems to harness its powerful anticancer properties safely.
Application
Currently, calicheamicin is not used clinically due to its high toxicity. However, it remains a critical reference compound in cancer research, providing insights into the mechanisms of action of DNA-damaging agents. Scientists study calicheamicin to understand how its potent cytotoxicity can be leveraged in cancer treatments, potentially through the development of safer derivatives or improved delivery methods.
Articles:
- An Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia. Choice of Linker
Publication Date: December 19, 2001
Philip R. Hamann, Lois M. Hinman, Carl F. Beyer, Delores Lindh, Janis Upeslacis, David A. Flowers, and Irwin Bernstein
https://doi.org/10.1021/bc0100206
- Understanding and Exploiting Natures Chemical Arsenal: The Past,Present and Future of Calicheamicin Research
Publication Date: 2000
Jon S. Thorson, Eric L. Sievers, Joachim Ahlert, Erica Shepard, Ross E. Whitwam, Kenolisa C. Onwueme and Mark Ruppen
http://dx.doi.org/10.2174/1381612003398564
- The Calicheamicin Gene Cluster and Its Iterative Type I Enediyne PKS
Publication Date: 16 Aug 2002
JOACHIM AHLERT, ERICA SHEPARD, NATALIA LOMOVSKAYA, EMMANUEL ZAZOPOULOS, ALFREDO STAFFA, BRIAN O. BACHMANN, KEXUE HUANG, LEONID FONSTEIN, ANNE CZISNY, ROSS E. WHITWAM, CHRIS M. FARNET AND JON S. THORSON